Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnost...
The Value Chain Beyond Aggregators: Unpacking the Hidden Plumbers of the U.S. Market
Radiopharm Dips on Securities Pact
US Stocks Mixed; American Express Shares Fall Following Q2 Results
12 Health Care Stocks Moving In Friday's Pre-Market Session
Radiopharm Theranostics calls extraordinary shareholder meeting
Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan | RADX Stock News